Stock 7779 CYBERDYNE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CYBERDYNE Inc.

Equities

7779

JP3311530004

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-05 am EDT 		5-day change 1st Jan Change
206 JPY +0.49% Intraday chart for CYBERDYNE Inc. -2.83% -8.04%
May. 15 U.S. FDA Becomes the world's First to Clear Smaller Model of Medical HAL and Expanded Indication for Cerebral Palsy CI
Apr. 30 Cyberdyne May Book 18 Million Yen Provision for Doubtful Accounts in Fiscal 2024 Due to Non-collectable Claims MT

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 86,057 137,473 78,309 59,962 44,971 43,282 - -
Enterprise Value (EV) 1 76,883 112,183 58,056 43,323 25,634 23,491 23,091 22,191
P/E ratio -563 x -2,367 x -159 x -204 x -30.5 x -146 x 80.4 x 37.6 x
Yield - - - - - - - -
Capitalization / Revenue 48 x 73.3 x 36.4 x 18.2 x 10.3 x 8.78 x 6.59 x 5.39 x
EV / Revenue 42.9 x 59.8 x 27 x 13.2 x 5.89 x 4.77 x 3.52 x 2.76 x
EV / EBITDA -141 x -473 x -147 x -83.6 x -19.1 x -66.5 x 30.8 x 25.3 x
EV / FCF - -31.4 x -24.9 x -72.9 x -8.76 x -90 x 46.1 x 40.8 x
FCF Yield - -3.18% -4.02% -1.37% -11.4% -1.11% 2.17% 2.45%
Price to Book 1.94 x 3.14 x 1.8 x 1.42 x 1.1 x 1.05 x 1.02 x 0.99 x
Nbr of stocks (in thousands) 215,141 215,137 215,134 211,134 211,131 211,131 - -
Reference price 2 400.0 639.0 364.0 284.0 213.0 205.0 205.0 205.0
Announcement Date 5/15/20 5/14/21 5/13/22 5/15/23 5/15/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 1,792 1,875 2,150 3,289 4,354 4,928 6,568 8,036
EBITDA 1 -547 -237 -395 -518 -1,341 -353 750.5 876
EBIT 1 -1,039 -700 -868 -1,145 -2,018 -1,080 -151.5 656
Operating Margin -57.98% -37.33% -40.37% -34.81% -46.35% -21.92% -2.31% 8.16%
Earnings before Tax (EBT) 1 91 408 -379 53 -1,141 -430 823.5 1,756
Net income 1 -152 -59 -492 -298 -1,476 -300 538.5 1,156
Net margin -8.48% -3.15% -22.88% -9.06% -33.9% -6.09% 8.2% 14.39%
EPS 2 -0.7100 -0.2700 -2.290 -1.390 -6.990 -1.400 2.550 5.450
Free Cash Flow 1 - -3,569 -2,334 -594 -2,925 -261 500.5 544.5
FCF margin - -190.35% -108.56% -18.06% -67.18% -5.3% 7.62% 6.78%
FCF Conversion (EBITDA) - - - - - - 66.69% 62.16%
FCF Conversion (Net income) - - - - - - 92.94% 47.1%
Dividend per Share - - - - - - - -
Announcement Date 5/15/20 5/14/21 5/13/22 5/15/23 5/15/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S2 2021 S1 2021 S2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4
Net sales 1 969 794 1,081 825 521 803 1,325 751 791 1,542 832 915 1,747 1,045 1,059 2,104 1,115 1,135 1,110 1,190 2,300 1,230 1,398
EBITDA - - - - - - - - - - - - - - - - - - - - - - -
EBIT 1 -659 -362 -338 -480 -170 -218 -388 -174 -268 -442 -307 -396 -703 -308 -1,009 -1,317 -286 -415 -250 -270 -520 -270 -290
Operating Margin -68.01% -45.59% -31.27% -58.18% -32.63% -27.15% -29.28% -23.17% -33.88% -28.66% -36.9% -43.28% -40.24% -29.47% -95.28% -62.6% -25.65% -36.56% -22.52% -22.69% -22.61% -21.95% -20.74%
Earnings before Tax (EBT) 85 442 -34 -388 -160 169 9 376 -3 373 -261 -59 -320 767 -947 -180 -386 -575 - - - - -
Net income -40 167 -226 -427 -159 95 -65 244 24 268 -200 -366 -566 330 -933 -603 -348 -525 - - - - -
Net margin -4.13% 21.03% -20.91% -51.76% -30.52% 11.83% -4.91% 32.49% 3.03% 17.38% -24.04% -40% -32.4% 31.58% -88.1% -28.66% -31.21% -46.26% - - - - -
EPS - 0.7800 - -1.990 -0.7400 - - 1.130 - 1.250 -0.9300 - - 1.560 - -2.850 -1.660 - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - - - - -
Announcement Date 5/15/20 11/13/20 5/14/21 11/12/21 2/14/22 5/13/22 5/13/22 8/12/22 11/14/22 11/14/22 2/14/23 5/15/23 5/15/23 8/14/23 11/14/23 11/14/23 2/14/24 5/15/24 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - - - - - - - -
Net Cash position 1 9,174 25,290 20,253 16,639 19,337 19,791 20,191 21,091
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -3,569 -2,334 -594 -2,925 -261 501 545
ROE (net income / shareholders' equity) -0.34% -0.16% -1.13% -0.7% -3.56% -0.7% 1.3% 1.2%
ROA (Net income/ Total Assets) -2.22% 0.85% - -0.6% -2.28% - - -
Assets 1 6,843 -6,936 - 49,824 64,801 - - -
Book Value Per Share 2 206.0 203.0 202.0 199.0 193.0 195.0 201.0 208.0
Cash Flow per Share 1.580 1.880 -0.0900 1.530 -3.780 - - -
Capex 1 405 1,070 1,770 451 216 727 614 639
Capex / Sales 22.6% 57.07% 82.33% 13.71% 4.96% 14.75% 9.35% 7.95%
Announcement Date 5/15/20 5/14/21 5/13/22 5/15/23 5/15/24 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for CYBERDYNE Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
205 JPY
Average target price
320 JPY
Spread / Average Target
+56.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CYBERDYNE INC. Stock CYBERDYNE Inc.
-8.04% 269M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+20.64% 85.53B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.19% 71.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.99% 26.76B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.35% 17.43B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.31% 17.18B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.19% 15.65B
NATERA, INC. Stock Natera, Inc.
+78.22% 13.71B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.09% 13.1B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.75% 13.27B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 7779 Stock
  4. Financials CYBERDYNE Inc.